CD40LG and COVID-19: Nevertheless, when equal amounts of purified total IgM were incubated with spike S1 from the severe and nonsevere COVID-19 cohorts, we observed a 2.8-fold higher rate of IgM-dependent complement deposition in the severe COVID-19 cohort (68.5%) versus the nonsevere cohort (24.3%) (Fig. 6c).